Navigation Links
Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide
Date:5/16/2011

WASHINGTON, May 16, 2011 /PRNewswire/ -- A poster entitled, "Time to Progression in Patients with Prostate Cancer: A Comparison of Continuous Degarelix versus Degarelix Following Leuprolide Treatment," is being presented at the American Urological Association 2011 meeting by E. David Crawford, MD, head of the Section of Urologic Oncology at the University of Colorado Health Sciences Center in Denver, and lead study investigator. The full manuscript has just been accepted and will be published in the September 2011 issue of the Journal of Urology.  Other investigators for the study, sponsored by Ferring Pharmaceuticals Inc., included J.W. Moul, N. Shore, E. van der Meulen, and B.E. Persson.

These latest PSA results were observed in the 5-year extension study portion (CS21A) of a pivotal one-year, open-label, randomized phase III trial (CS21)  that evaluated the efficacy of FIRMAGON, a gonadotropin-releasing hormone (GnRH) antagonist, and leuprolide, a luteinizing hormone-releasing hormone (LHRH) agonist, and formed the primary basis of the approval of FIRMAGON for advanced prostate cancer.    

After one year, 384 patients entered CS21A and 134 who had received leuprolide were re-randomized to receive FIRMAGON.  The purpose of the extension study was to evaluate the safety and tolerability during long-term treatment with once-monthly injections of FIRMAGON 80 mg in patients with prostate cancer.  Exploratory efficacy endpoints were evaluated and included: serum levels of PSA over time, cumulative probability of no PSA failure, serum levels of testosterone over time, cumulative probability of testosterone level maintained at less than or equal to 0.5 ng/dL from Day 28 in CS21 and onwards, and serum levels of testosterone, PSA, LH, and FSH from the time of switch from leuprolide to degarelix.

Both the cumulative probability of no PSA failure and the cumulative probability of testosterone levels below c
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial of PSI-7977 for Chronic Hepatitis C
2. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
3. Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009
4. PRA International: Participating Sponsor for Exploratory Clinical Development World in London
5. BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device
6. Shionogi Inc. Announces Publication of Data in Pediatrics Demonstrating Efficacy of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets as Add-On Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
7. REMEDIAL II Trial of PLCs RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care
8. Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS Elevate Anterior and Apical Prolapse Repair System
9. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
10. Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action
11. Independent Clinical Research Confirms Clinical Efficacy and Cost-Effectiveness of the SurgiCount Safety-Sponge® System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 PuraMed BioScience ® , ... over-the-counter (OTC) medicinal and healthcare products, announced today ... name along with the name,s red and yellow ... trademarked name MigraPure ®  going forward. The ... homeopathic, natural migraine pain reliever will be reintroduced ...
(Date:7/30/2014)... , July 30, 2014 Research and Markets ... Market - Forecasts to 2019" report to their offering. ... is estimated to grow at a lower CAGR in developed countries; ... such as China , India ... years. The growth of the hematology analyzers and reagents ...
(Date:7/30/2014)... RATON, Fla. , July 30, 2014  Today the ... for indoor and outdoor sun tanning or sun burns stating ... his statement Surgeon, General Boris Lushniak , says that ... skin types and that too much exposure to indoor and ... Center for Dermatology and Aesthetic Medicine, in Boca ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2
(Date:7/30/2014)... July 30, 2014 The American ... U.S. Sens. Thad Cochran (R-MS) and Roger Wicker ... in telemedicine coverage under Medicare, Medicaid and Federal ... both Mississippi Republicans, introduced the Telehealth Enhancement Act ... House version, H.R. 3306, introduced by Rep. Gregg ...
(Date:7/30/2014)... Portland, OR (PRWEB) July 30, 2014 ... and evaluating the quality of care that their ... company’s CEO, Mr. Andrew Rowe, discussed the importance ... order to improve physician performance and quality of ... for effective practitioner evaluation, Mr. Rowe elaborated on ...
(Date:7/30/2014)... Aquarium Research Institute (MBARI) have observed a deep-sea octopus ... than any other known animal. Throughout this time, the ... predators. This amazing feat represents an evolutionary balancing act ... plenty of time to develop within their eggs, and ... or no food. , Every few months for the ...
(Date:7/30/2014)... Frozen shoulder (Adhesive capsulitis) affects 10-20 percent of ... nasty condition which occurs most frequently in people between the ... two and half years if not treated. , Adhesive capsulitis ... reason: it can render your shoulder so stiff, it's almost ... aren't in too much pain to get dressed in the ...
(Date:7/30/2014)... 2014 (HealthDay News) -- For patients with asthma, just ... trigger airway inflammation for at least 24 hours, a ... smell, but also what you think you smell," study ... Center in Philadelphia, said in a Monell news release. ... fragrances. When we expect that an odor is harmful, ...
Breaking Medicine News(10 mins):Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2
... A53A iceberg located just east of the South Georgia ... Ocean. , A huge fissure was spotted running south ... C-CORE, the Canadian ice-tracking service, while studying satellite images ... using the Polar View monitoring programme. , The radar ...
... study finds , , FRIDAY, March 14 (HealthDay News) -- Higher ... harm older men, U.S. research shows. , A ... followed 1,000 seniors in three Florida retirement communities for up ... levels of anxiety at the start of the study lived ...
... and Meet with Elected,Officials, WASHINGTON, March 14 ... D.C., this April 1 to meet with,congressional leaders and ... Act, support for epilepsy public health,programs and more research ... one of 50 young people with epilepsy participating in,Kids ...
... to Visit Washington, D.C., and Meet with Elected,Officials, ... will travel to Washington, D.C., this April 1 to ... of the,Americans with Disabilities Act, support for epilepsy public ... Foster, 16, is one of 50 young people ...
... Management,Services, Inc. (Nasdaq: BDMS ), operators of ... The Company,s board of directors,has declared a quarterly ... common,stock. The dividend is payable April 11, 2008, ... Dental Management Services, Inc. acquires, develops, and manages,geographically ...
... weight rapidly after having their tonsils and adenoids removed ... short-term, but over time they may relapse or even ... new research from Cincinnati Childrens Hospital Medical Center. ... children, ranging from about 19 per 10,000 in Canada ...
Cached Medicine News:Health News:Anxiety Helps Elderly Women Live Longer 2Health News:Colorado Youth Named National Epilepsy Spokesperson 2Health News:Virginia Youth Named National Epilepsy Spokesperson 2Health News:The ABCs of childhood z's: Snoring may be chronic despite surgery 2
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... modification of the Farnsworth-Munsell 100 Hue Test. It ... the in-depth study of a color vision defect. ... ease or difficulty in distinguishing color differences in ... 15 color reference caps with Munsell notations, plus ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
... HRR 4th edition pseudoisochromatic test from Richmond Products ... plates and the 14 diagnostic series for a ... has its own tab for easy and clean ... of instructions in English and a laminated copy ...
Medicine Products: